Diversity and inclusionTalent acquisition/retentionManaging growthGetting an audience, virtually or otherwise, with HCPsKeeping up with pace of innovationReplenishing new-business pipelineNetwork relationships/agency consolidationShrinking pharma budgetsFurther diversification of servicesRegulatory concernsCompetition from consultancies and other non-traditional organizationsPandemic-related disruptions
Healthcare Marketing Trends
More personalization of communicationsNeed to create more/better content/experiencesHeightened focus on payersIncreased concern over drug pricingIndustry consolidationScrutiny around social mediaImpact of empowered patients/consumersIntensified focus on analytics/ROI/measurementDecreased impact of sales forcesPrograms that go “beyond the pill”Evolution of EHRsEmphasis on specialty drugs/high-science categoriesAdopting a data-science cultureMore digital experimentationSeizing opportunities around cannabisWorking from homeOngoing fallout from pandemic
Why data-driven linear is the last piece of the marketing puzzle
Reduce waste, optimize media and achieve cross-channel attribution by unifying television.
Fifth CIIE to bring strong Chinese market to global pharmaceutical enterprises
The Medical Equipment and Healthcare Products exhibition area at the CIIE has become an important platform for global pharmaceutical enterprises to explore the Chinese market and share development opportunities in China.
Video: Why privacy changes demand a better approach to targeting: Real world data
Building custom audience segments can help marketers better reach consumers.
An all-in agency approach to challenging the status quo in oncology marketing
Differentiating science, technology, and brand innovation has never been more important across complex and crowded specialty markets.